Proveca Ltd is a pharmaceutical company specializing in identifying, developing and licensing off-patent medicines with the focus on the pediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation these drugs will benefit from a period of 10 years' market protection. Proveca has a strong pipeline of relevant, optimal candidates identified from its methodology, research, and analysis process. Several products have been taken through scientific advice with the European Medicines Agency, 2 Paediatric Investigation Plans (PIPs) have been granted to date and several others are in process.